top of page
In the States.jpg


The biopharmaceutical sector has a positive impact in the U.S. by providing jobs, economic output & clinical trial data. Beyond these traditional indicators, however, its full economic footprint can be measured in part by its impact on the vendors, large and small, that provide services or supplies to America’s biopharmaceutical research companies.

To provide insight into the breadth and depth of the industry’s direct impact, We Work For Health gathered 2022 vendor and supplier expenditure data from 15 biopharmaceutical companies in 50 states, the District of Columbia and Puerto Rico.

Direct Jobs Supported by the Industry


Total Jobs Supported by the Industry


Total Vendor Spending


Total Clinical Trials


Click on each state for detailed info illustrating jobs & economic impact data, clinical trial data, and vendor/supplier data:

bottom of page